Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
157
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+247K
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
+$10.9M
-
Put/Call ratio
-
1.12
-
Number of buys
-
57
-
Number of sells
-
-75
-
Price
-
$45.28
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2016
172 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q4 2016.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 157 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
of 835M outstanding shares and own 3.26% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5.62M shares), COMMONWEALTH BANK OF AUSTRALIA (3.84M shares), ROYAL BANK OF CANADA (2.53M shares), AQR CAPITAL MANAGEMENT LLC (2.29M shares), VANGUARD GROUP INC (1.47M shares), VONTOBEL ASSET MANAGEMENT INC (1.2M shares), BlackRock Group LTD (889K shares), JPMORGAN CHASE & CO (649K shares), DIMENSIONAL FUND ADVISORS LP (638K shares), and HSBC HOLDINGS PLC (636K shares).
This table shows the top 157 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.